A recent study looked at whether a cost-effective finger-prick whole-blood test for toxoplasmosis can reliably detect the presence of the parasite Toxoplasma gondii. PLUS: Cell-free DNA (cfDNA) tests are increasingly being offered to women in the first trimester of pregnancy but results from a recent study suggest cfDNA tests may not significantly reduce miscarriage risk.
Doctors in high-stress environments may have the right information but don’t always act on it correctly, study finds.
Contemporary OB/GYN launched the Maternal Mortality Special Series in January with a guest editorial from the series editor, Carolyn Zelop, MD. This quiz goes over some of the important takeaways on the issues she covered. If you need a refresher before taking the quiz, her article can be found here. The answers to each question can be found on the following page.
A collection of standards, guidelines, tools and articles for the OB interested in learning more about initiatives organizations are taking to reduce maternal mortality.
A study that tested the hypothesis that polycystic ovary syndrome (PCOS) is linked with autism may inform new interventions for PCOS and autism. PLUS: Does smoking exposure deter breastfeeding? ALSO: Does race play a role in maternal outcomes for older women?
Women who give birth in rural areas face unique challenges because of geography but state-based data collection hampers efforts to understand and address the factors that place them at particular risk for morbidity and mortality.
A national poll suggests that most adults with children favor some type of state support for pregnant teens. But how strongly someone feels about that and whether the help comes with caveats may be influenced by the person’s gender.
Internet addiction often is linked with depression but a new study suggests that there is a way to use the technology to help encourage teens with postpartum depression to get treatment.
Research presented during the Pediatric Academic Society (PAS) 2018 Meeting suggests that when it comes to decision-making about hormone therapy (HT), transgender teens and their parents may have different views about preserving biologic fertility.
Intrauterine devices (IUDs) are a highly effective form of long-acting reversible contraception but insertion can be associated with discomfort. In a new study, researchers from Pennsylvania sought to quantify the impact of the procedure on IUD satisfaction in younger women.
Doctors don’t talk enough to their young patients about sex, and neither do parents-but parents also aren’t sure that it’s a clinician’s place to have “the talk” with their children, according to a new study.
Ventriculomegaly, or dilation of the fetal cerebral ventricles, is a relatively common finding on prenatal ultrasound. This summary of SMFM Consult Series #45 reviews key points for diagnosis, evaluation, and management of mild fetal ventriculomegaly.
Complications following IUD removal were the focus of this lawsuit.
These are the eight steps for successfully launching virtual visits in low- and high-risk obstetrics and gynecology.
Dr. Charles J. Lockwood sits down with Linda Marie Wetzel, Executive Editor for Contemporary OB/GYN, to discuss the results of the ARRIVE study and what these findings mean for ob/gyns and their patients.
More than half of rural counties in the United States have no hospital obstetrical services, many remaining services are closing at a frightening pace, and maternal and perinatal mortality and/or morbidity are rising as a consequence.
Release of results from the ARRIVE trial has provided answers to some concerns about 39-week induction while leading to some questions about the participants and the implication of the findings for clinical practice. PLUS: CDC updates on Zika virus. Also: FDA warns about tests for rupture of membranes
Dilator therapy can be extremely successful in treating superficial dyspareunia, but compliance is often poor. A new type of vaginal dilator that gives women more control aims to address the issue.
A recent study quantified how much the treatment effect of pharmacologic modalities for female sexual dysfunction could be attributed to the placebo effect.
To fight the opioid epidemic, ob/gyns, like all physicians, are looking for ways to help prevent substance use disorders and enhanced recovery programs (ERAS) could play a role. PLUS: Are EDs screening adolescents with PID for HIV, syphilis? ALSO: Results of a new retrospective study show that a woman’s race may impact how likely she is to have a myomectomy-and alarmingly, whether the procedure is likely to result in morbidity.
A recent study examined whether severe and/or chronic abuse of multiple types during childhood and adolescence increases a woman's risk of endometriosis.
Frequent fatigue affects a full half of women diagnosed with endometriosis. However, physicians are not discussing management and treatment strategies with their patients.
Incidence of acute myocardial infarction (AMI) continues to increase in women during pregnancy and the puerperium. Data from a new study point to underlying factors contributing to that trend. PLUS: Results of a large population-based study of POP procedures provide new insights into what factors other than the material may play a role in the adverse surgical outcomes.
The manufacturer of a device for permanent birth control that reportedly causes serious adverse events has decided to cease selling it at the end of the year. PLUS: Does smoking cessation really = weight gain? Also: Is prenatal depression more common today?
Ob/gyns and other women’s health providers can help save Title X for their patients and their voices need to be heard on Capitol Hill. That was the clear message from speakers at a recent media event in Washington, DC.
Risk of postop urinary retention may vary depending on when devices are removed.
Uropathogens may not be the only bacteria shared between the vagina and bladder.
Research point to risk as well as benefits of extended adjuvant tamoxifen for ER-positive BCa. PLUS: Should breast cancer screening be risk-based? ALSO: Side effects of cross-sex hormones in transwomen.
A meta-analysis of 140 studies by investigators from the Cochrane Collaboration shows that oxytocin may not be the best choice for prevention of postpartum hemorrhage, despite the current recommendation from the World Health Organization (WHO). PLUS: Commentary on the findings from our Maternal Mortality Series Editor, Carolyn Zelop, MD.